- Sputnik International, 1920
Russia
The latest news and stories from Russia. Stay tuned for updates and breaking news on defense, politics, economy and more.

Russia's Chumakov Centre to Produce 7.5 Mln CoviVac Doses by Year's End

© Chumakov research instituteIn this handout photo released by the Chumakov research institute, Russia's CoviVac coronavirus vaccine, the third vaccine against COVID-19 registered in Russia, is pictured in Moscow, Russia
In this handout photo released by the Chumakov research institute, Russia's CoviVac coronavirus vaccine, the third vaccine against COVID-19 registered in Russia, is pictured in Moscow, Russia - Sputnik International, 1920, 02.05.2021
Subscribe
PETROPAVLOVSK-KAMCHATSKIY (Sputnik) - Russia's Chumakov research centre plans to produce at least 7.5 million doses of its coronavirus vaccine CoviVac by the end of the year, the institute's director general, Aidar Ishmukhametov, said on Sunday.
"By the end of the year, I suppose there will be about 7.5 million [doses] at least", Ishmukhametov said to the Rossiya 1 broadcaster.

The head of the centre added they had applied for authorisation from the Russian Health Ministry to administer their vaccine to people over 60 years old, noting that immunity developed after the CoviVac shot would last some eight months.

Russia's Chumakov research centre officially launched production of the nation's third coronavirus vaccine, CoviVac, in late March.

CoviVac is a so-called whole-virion vaccine based on a modified SARS-CoV-2 virus that is unable to cause the disease but boosts immunity against coronavirus. The vaccine was developed from samples taken from a COVID-19 patient.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала